On July 9th, the Chinese herbal medicine index was 2,709 points, unchanged from yesterday, a decrease of 1.53% from the cycle's highest point of 2,751 points (2023-06-26), and an increase of 177.85% from the lowest point of 975 points on November 25th, 2019. (Note: The cycle refers to June 30th, 2019 to present)

According to the price monitoring of SunSirs, in the 27th week of 2023 (7.3-7.7), there were 2 products that rose, 2 products that fell, and 4 products that rose or fell to 0 on the Chinese herbal medicine price list. The main commodities that rose were: Ophiopogon japonicus (1.21%) and Flos Lonicerae (1.06%); The main commodities that fell were: Forsythia (-2.41%) and Angelica (-1.85%). Last week's average increase or decrease was -0.25%.

According to the monitoring of the commodity market analysis system of SunSirs, In the early stage, the supply of Astragalus was smooth and the market was rising. Recently, the supply of Astragalus was mostly actual sales, and the price stabilized. Currently, the price of 0.8-1 Astragalus in the market is 42 RMB, 0.8-1.2 RMB is 44 RMB, and 1.2 RMB or above is 55 RMB.

The market volume of Huangqi in Minxian County has increased, and the market flow of people is stable. The main buyers are local processing and operating households. In recent years, the trading volume of Jizi and Jiezi sources has been moderate, and the transaction price is firm. The overall trading is stable and fast. 0.6-0.8cm Huangqi section is priced at 32-35 RMB/kg, 1.0-1.2cm Huangqi section is priced at 44-47 RMB/kg. The transaction price of raw materials for raw materials from the pharmaceutical factory is between 23-24 RMB/kg, the transaction price for raw materials is between 17-19 RMB/kg, and the transaction price for net raw materials is between 20-23 RMB/kg.

Compared to Angelica sinensis and Codonopsis pilosula, Astragalus cultivation has a higher degree of mechanization, a wider planting area, and varieties that are cold and drought resistant are less affected by climate. The demand side and supply side are relatively balanced in the long term. According to statistics, the national production of Astragalus in 2021 was about 46,000 tons, and in 2022, the production of Astragalus was about 45,000 tons. In 2021, the national consumption of Astragalus was about 37,000 tons, and in 2022, the consumption of Astragalus was about 41,000 tons.

The booming market of Angelica and Codonopsis pilosula has briefly boosted the market of Astragalus. However, Astragalus has a large inventory and insufficient upward momentum. Business analysis suggests that Astragalus may still maintain a strong and stable operation.

With the continuous high temperature weather throughout the country, the Chinese herbal medicine market has entered the traditional off-season, with low overall trading volume, limited market hotspots, and limited attention from merchants. Some varieties that missed the price increase in the early stage have performed well in the near future, but clearly lack the drive of star varieties; The trading volume of the declining variety market this week has further shrunk, lacking practical digestion, and merchants are also unwilling to sell at reduced prices.

If you have any questions, please feel free to contact SunSirs with support@sunsirs.com.